A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265

NCT02389348 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: DSM265
DRUG: OZ439

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]
[object Object]
[object Object]